How many institutions own DRMA stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own DRMA shares is 10, representing 7.46% of the company's common stock.

Who are the major shareholders selling Dermata Therapeutics, Inc. stock?

TUDOR INVESTMENT CORP ET AL, in the last quarter, reduced its stake in DRMA by -100% restricting it's holding to 0 shares of worth nearly -. GEODE CAPITAL MANAGEMENT, LLC also lessened -100% of the DRMA shares from its portfolio, reducing its holding to 0 shares of worth -. TWO SIGMA SECURITIES, LLC also shunned DRMA shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying DRMA stock?

As per its latest 13F filing, HC ADVISORS, LLC increased its stake in DRMA by 100% in the last quarter. The institutional holder raised its holding to 10 thousand shares having worth more than $4.09K. RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. also added 100% more shares of DRMA to its portfolio, raising its holding to 141.76 thousand shares of worth $57.98K. WELLS FARGO & COMPANY/MN also increased its DRMA shares holding by 0.08% which brought its holding to 24.44 thousand shares worth $10.00K.

DRMA's major insiders: who are they?

The insider with the most stakes in DRMA is PROEHL GERALD T , President, CEO and Chairman at the company. Additionally, DRMA stock is highly held by director HALE DAVID F and N/A N/A among others.

Did an insider recently sell DRMA stock?

Company executives, directors, and other insiders own 17% percent of Dermata Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which DRMA insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Which insider recently purchased DRMA stock?

There have been 0 transaction(s) during the past 6-months in which Dermata Therapeutics, Inc. insiders have bought stock, totalling 0 shares

How much of DRMA does insiders own?

Around 0 Dermata Therapeutics, Inc. shares are held by insiders, which represents about 17% of DRMA stock.

Who is the insider with the largest stake?

DRMA President, CEO and Chairman, PROEHL GERALD T holds the largest portfolio of the company's shares. DRMA shares owned by PROEHL total nearly 59.51 thousand.

Which institution holds the most shares in DRMA?

TUDOR INVESTMENT CORP ET AL is the largest institutional owner in DRMA which holds 0 shares worth - or 0% of the total DRMA shares outstanding followed by GEODE CAPITAL MANAGEMENT, LLC with ownership of 0 shares representing 0% of the DRMA ownership. TWO SIGMA SECURITIES, LLC is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Is Dermata Therapeutics, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the DRMA is concerned, it is a stock which is not optionable.

Is there a short position on DRMA's shares?

Number of DRMA shares short is 13.00K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding DRMA shares are there?

As of today, 681.56K shares of DRMA are outstanding.

Is there many float in DRMA stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, DRMA has 498.47K shares in float.

DRMA short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for DRMA is 0.44.

Stock Ideas

DRMA Stock Ownership Breakdown

NASDAQ : DRMA

Dermata Therapeutics

$1.93

0.65+50.78%

At Close 4:00 PM

$1.81

−0.12-6.22%

After-Market 08:00 PM

66.29

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares1.91

Short Percent Of Float3.23

Shares Outstanding681.56K

Shares Float498.47K

Shares Short13.00K

Short Ratio0.44

3.23%

Short % of Float

1.91%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

17% Percentage of Shares held by All Insiders

7.46% Percentage of Shares held by All Institutions

8.98% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 7.46% of DRMA shares are held by financial institutions. TUDOR INVESTMENT CORP ET AL is the top corporate investor, holding 0 shares valued at -. A 0% stake in Dermata Therapeutics, Inc. is owned by the company. GEODE CAPITAL MANAGEMENT, LLC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2023	TUDOR INVESTMENT CORP ET AL	0%	0	-	-10.21K	-100.00%
Mar 31, 2023	GEODE CAPITAL MANAGEMENT, LLC	0%	0	-	-26.67K	-100.00%
Mar 31, 2023	TWO SIGMA SECURITIES, LLC	0%	0	-	-12.43K	-100.00%
Mar 31, 2023	RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.	0%	0	-	-141.76K	-100.00%
Mar 31, 2023	TOWER RESEARCH CAPITAL LLC (TRC)	0%	0	-	-4.69K	-100.00%
Mar 31, 2023	FAS WEALTH PARTNERS, INC.	0%	0	-	-12.7K	-100.00%
Mar 31, 2023	UBS GROUP AG	0%	0	-	-37.31K	-100.00%
Mar 31, 2023	SAGE CAPITAL ADVISORS,LLC	0%	0	-	-12K	-100.00%
Mar 31, 2023	HC ADVISORS, LLC	0%	0	-	-10K	-100.00%
Mar 31, 2023	WELLS FARGO & COMPANY/MN	0%	0	-	-24.44K	-100.00%
Mar 31, 2023	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	0%	0	-	0	0
Mar 31, 2023	MORGAN STANLEY	0%	0	-	-562	-100.00%
Dec 31, 2022	SAGE CAPITAL ADVISORS,LLC	1.56%	12K	4.91K	0	0
Dec 31, 2022	TUDOR INVESTMENT CORP ET AL	1.33%	10.21K	4K	0	0
Dec 31, 2022	HC ADVISORS, LLC	1.3%	10K	4.09K	10K	+100.00%
Dec 31, 2022	TOWER RESEARCH CAPITAL LLC (TRC)	0.61%	4.69K	2K	-84	-1.76%
Dec 31, 2022	JANE STREET GROUP, LLC	0%	0	-	-23.57K	-100.00%
Dec 31, 2022	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	0%	0	-	0	0
Dec 31, 2022	RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.	18.48%	141.76K	57.98K	141.76K	+100.00%
Dec 31, 2022	WELLS FARGO & COMPANY/MN	3.19%	24.44K	10K	20	+0.08%
Dec 31, 2022	UBS GROUP AG	4.86%	37.31K	15.3K	22.51K	+152.12%
Dec 31, 2022	GEODE CAPITAL MANAGEMENT, LLC	3.48%	26.67K	10K	0	0
Dec 31, 2022	FAS WEALTH PARTNERS, INC.	1.65%	12.7K	5.19K	12.7K	+100.00%
Dec 31, 2022	TWO SIGMA SECURITIES, LLC	1.62%	12.43K	5.09K	12.43K	+100.00%
Dec 31, 2022	MORGAN STANLEY	0.07%	562	230	562	+100.00%
Dec 31, 2022	FMR LLC	0%	0	-	-10K	-100.00%
Dec 31, 2022	VIRTU FINANCIAL LLC	0%	0	-	-70.81K	-100.00%

Insiders

Among the DRMA insiders holding of 17% of the stake in company, PROEHL GERALD T, President, CEO and Chairman, holds the largest shares of 59.51K. HALE DAVID F, director, is the second largest DRMA insider with ownership of 35.71K shares. , , stands third with possession of - shares of that stake.

Insiders	Designation	Shares Held
PROEHL GERALD T	President, CEO and Chairman	59.51K
HALE DAVID F	director	35.71K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Nov 23, 2021	PROEHL GERALD T	PURCHASE	2.40	20K	48K	59.51K
Aug 17, 2021	HALE DAVID F	PURCHASE	7.00	35.71K	250K	35.71K
Aug 16, 2021	PROEHL GERALD T	PURCHASE	4.96	10K	49.63K	10K

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.